Increasing Adherence to Lung Cancer Screening
Lung Cancer, Adherence, Patient

About this trial
This is an interventional prevention trial for Lung Cancer focused on measuring Screening, Nudge, Adherence, Implementation science, Behavioral science, Digital health
Eligibility Criteria
Inclusion Criteria: Clinicians will be eligible if they: are practicing primary care or specialty care physicians at a recruiting site within the University of Pennsylvania Health System; care for patients who completed LCS via LDCT in 2019-2022; and do not opt-out of study participation. Patients will be eligible if they: are eligible for LCS based on 2021 US Preventive Services Task Force (USPSTF) population guidelines (aged 50-80; smoking history of 20-pack years; smoked within the last 15 years) completed LCS via LDCT in 2019-2022; have not been diagnosed with lung cancer; meet criteria for non-adherence; remain eligible for LCS during the trial enrollment period; and receive LCS care from a clinician that has not opted-out of study participation Exclusion Criteria: Patients will be excluded if they: a) have a highly suspicious baseline LDCT (Lung-RADS 4B/X) given the presence of existing clinical pathways to ensure adherence in this group
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
No Intervention
Experimental
No Intervention
Clinician Nudge
No Clinician Nudge
Patient Nudge
No Patient Nudge
A pended order will prompt clinicians in this arm when a patient is due for lung cancer screening or diagnostic follow-up.
Clinicians in this arm will not be prompted by a pended order when a patient is due for lung cancer screening or diagnostic follow-up.
Patients in this arm will receive messaging designed to increase awareness of the benefits of LCS and remind patients that they are due for screening or recommended follow-up care.
Patients in this arm will receive usual care.